ARVO 2018: Port Delivery System Designed to Reduce Burden of Lucentis Injections for Wet AMD

Dr. Christopher Brittain, Genentech medical director, discusses his company’s port delivery system, a tiny capsule implanted into the eye, for delivery of Lucentis® over a period of a few months. The device is currently in a Phase 2 clinical trial. The image below shows the port implanted into an eye. implant_2-300x177.jpg

https://www.lvcenter4sight.com/arvo-2018-port-delivery-system-designed-to-reduce-burden-of-lucentis-injections-for-wet-amd/

Comments

Popular posts from this blog

I Spy a Stye in Your Eye

Overuse of Contact Lenses

Eyelash Extensions – Yay or Nay?